Tuesday July 17, 2018
Home India Mitti ki Khus...

Mitti ki Khusboo (#Mitti_kiKhusboo): A unique way to Connect you to India

2
//
274
Indians. Wikimedia
Republish
Reprint

May 20, 2017: Mitti Ki Khusboo (Mitti_kiKhusboo) :

NRIs and PIOs can now connect to their motherland in a way you did never ever before. The professional script writers and videographers will weave the dream on both sides and give shape to your journey and success in a way that connects so naturally.

The campaign Mitti Ki Khusboo ( the smell of the motherland) is aimed at NRIs and PIOs. Our efforts are to connect you to India in a very personalized way. Our professional team will reach out to you in your country abroad and your family here in India. We will connect the story and weave into mesmerizing and everlasting impressions for you!

How does it happen? we are the storyteller for you and accomplish the task for you. For details, please contact Pankaj Singh, senior media professional based in Allahabad. Email: fmnfive@gmail.com and cell/Whatsapp: +91 955 555 1885. Chicago-based NewsGram will assist the work outside India.

Campaign #Mitti_KiKhusboo

Part 1

India is “the story”, with whom you wanted to associate with. The story which you wanted to tell to your next Generation

These take you to old days memories, friends, and families

o   Family Here in India – Their Folks

o   Your Town/City/Village

o   Your Agriculture fields

o   My First School

o   My Adda (Hangout) – My ultimate Masti

o   My Secrete places – The Feeling of Belonging

o   My local shop/chai walla

We help you to live your life again in your memory lane.

 Part 2

We will be your storyteller

 o   Share your story with Us

o   We will script it

o   We will make video/movie

o   Will run your story on our partner websites

o   And most important share your memories tradition with your Kids and families

Click here for reuse options!
Copyright 2017 NewsGram

  • sketch

    आप भोजपुरी, अवधी, संस्कृत, ब्रज और अन्य भाषाओं में भी लेख लिखे। पढ़ने में अच्छा लगता है।

  • sketch

    Please do write articles in Bhojpuri, Braj, Sanskrit and Awadhi. We love reading it.

Next Story

Cepheid to Establish Manufacturing Unit for TB Diagnostics in India

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment

0
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach. (IANS)

Expanding its footprint in India, US-based molecular diagnostics company Cepheid Inc on Thursday announced its plans to establish a manufacturing unit in the country to improve Tuberculosis (TB) diagnostics.

Cepheid’s GeneXpert MTB/RIF test is a closed-cartridge-based system that is easy to operate by minimally trained staff and gives results in approximately two hours, speeding the conventional backlog that used to exist in traditional diagnostic methods.

The new manufacturing unit would produce MTB/RIF test cartridges, contribute to the government’s “Make in India” initiative and thus bringing the company’s global expertise in TB diagnostics to India, the company said in a statement.

As part of the plan, Cepheid also unveiled its latest portable, easy-to-use TB-testing system — the GeneXpert Edge — which is expected to be available in India later this year, the company said.

The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.

“Cepheid recognises the need for technological advancement and is committed to contributing significantly to India’s goal of TB eradication,” said Peter Farrell, Executive Vice President, Worldwide Commercial Operations, Cepheid.

Cepheid's Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB)
Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB).

“We are hopeful that GeneXpert Edge will help eliminate delays in TB diagnostics by providing definitive results within hours and facilitating fast and easy last-mile delivery even in the remote villages of India,” he added.

India has nearly one-fourth of the global TB patients and an estimated 4.8 lakh lives are lost every year due to delayed diagnosis and inadequate treatment and there are above 2.5 million new cases of TB every year. The country aims to eradicate TB by 2025.

Approved by the World Health Organisation (WHO) in 2010, more than 1,200 Cepheid’s GeneXpert Systems have been installed in the last two years at various Revised National Tuberculosis Control Programme (RNTCP) sites in the country and more than 2.5 million cartridges were supplied last year at various centres of Central TB Division (CTD).

Also Read: Fruit Bats Identified As Source Of Nipah Virus Outbreak in Kerala

Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB) and rifampicin-resistance mutations, which are markers for MDR-TB strains in under two hours.

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment.

Xpert MTB/RIF tests also have excellent negative predictive value, which allows clinicians to manage TB-negative patients more effectively to prevent unnecessary and costly respiratory isolations. (IANS)